Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer

Clinical Genetics

Volumn 62, Issue 4, 2002, Pages 298-302

  Figer, A ^a   Kaplan, A ^b   Frydman, M ^c   Lev, D ^d   Paswell, J ^b   Papa, M Z ^b   Goldman, B ^c   Friedman, Eitan ^b,c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

Author keywords

DGGE; Germline mutations; Inherited predisposition to breast cancer; PTEN

Indexed keywords

ADENINE; ALANINE; ARGININE; ASPARAGINE; BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA; CYTOSINE; METHIONINE; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; THREONINE;

ADOLESCENT; ADULT; AGED; BANNAYAN RILEY RUVALCABA SYNDROME; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHILD; CLINICAL FEATURE; CODON; CONTROLLED STUDY; COWDEN SYNDROME; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ASSOCIATION; EXON; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC DISORDER; GENETIC SCREENING; GERM LINE; HIGH RISK PATIENT; HUMAN; INFANT; INHERITANCE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SHORT SURVEY; STOP CODON;

BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; ISRAEL; MUTATION, MISSENSE; NEOPLASTIC SYNDROMES, HEREDITARY; PHENOTYPE; PHOSPHORIC MONOESTER HYDROLASES; PIGMENTATION DISORDERS; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS; WOMEN'S HEALTH;

INSERTION SEQUENCES;

EID: 0036821809     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2002.620407.x     Document Type: Short Survey

References (29)

1. Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997: 275: 1943-1946.
2. Steck PA, Pershouse MA, Jasser SA et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997: 15: 356-362.
3. Cairns P, Okami K, Halachmi S et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 1997: 57: 4997-5000.
4. Mutter GL, Lin M-C, Fitzgerald JT, Kum JB, Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocr Metab 2000: 85: 2334-2338.
5. Liaw D, Marsh DJ, Li J et al. Germline mutations of PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997: 16: 64-67.
6. Nelen MRG, van Staveren WCJ, Peeters EA et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997: 6: 1383-1387.
7. Marsh DJ, Dahia PL. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997: 16: 333-334.
8. Marsh DJ, Coulon VH, Lunetta KL et al. Mutation spectrum and genotype - phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998: 7: 507-515.
9. Marsh DJ, Kum JB, Lunetta KL et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mole Genet 1999: 8: 1461-1472.
10. Celebi JT, Tsou HC, Chen FF et al. Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN. J Med Genet 1999: 36: 360-364.
11. Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M. Clinical and pathological features of breast cancer in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol 1998: 29: 47-53.
12. Easton DF, Bishop DT, Ford D, Cockford GP and the Breast Cancer Linkage Concortium. Genetic linkage analysis in familial breast an ovarian cancer. Am J Hum Genet 1993: 52: 718-722.
13. Tonin PN. Genes implicated in hereditary breast cancer syndromes. Sem Surg Oncol 2000: 18: 281-286.
14. Abeliovich D, Kaduri L, Lerer I et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 1997: 60: 505-514.
15. Frank TS, Manley SA, Olopade OI et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998: 16: 2417-2425.
16. Shiri-Sverdlov R, Oefner P, Green L et al. Mutational analysis of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast cancer. Hum Mut 2000: 16: 491-501.
17. Rohlfs EM, Learning WG, Friedman KJ, Couch FJ, Weber BL, Silverman LM. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem 1997: 43: 24-29.
18. Marsh DJ, Dahia PL, Caron S et al. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 1998: 35: 881-885.
19. Carethers JM, Furnari FB, Zigman AF et al. Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res 1998: 58: 2724-2726.
20. Bonneau D, Longy M. Mutations of the human PTEN gene. Hum Mut 2000: 16: 109-122.
21. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000: 100: 387-390.
22. De Vivo I, Gertig DM, Nagase S et al. Novel germline mutations in the PTEN tumor suppressor gene found in women with multiple cancers. J Med Genet 2000: 37: 336-341.
23. FitzGerald MG, Marsh DJ, Wahrer D et al. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene 1998: 17: 727-731.
24. Tsou HC, Teng DH-F, Ping XL et al. The role of MMAC1 mutations in early onset breast cancer: causative in association with Cowden Syndrome and excluded in BRCA1-negative cases. Am J Hum Genet 1997: 61: 1036-1043.
25. Lauge A, Lefebvre C, Laurent-Puig P et al. No evidence for germline PTEN mutations in families with breast and brain tumours. Int J Cancer 1999: 84: 216-219.
26. Chen J, Lindblom P, Lindblom A. A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet 1998: 102: 124-125.
27. Freihoff D, Kempe A, Beste B et al. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Br J Cancer 1999: 79: 754-758.
28. Lynch ED, Ostermeyer EA, Lee MK et al. Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and Juvenile polyposis. Am J Hum Genet 1997: 61: 1254-1260.
29. Shugart YY, Teare D, Rahman N et al. Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer. J Med Genet 1999: 36: 720-721.